‘Caught between a rock and a hard place’: FDA considers over-the-counter birth control

France Nouvelles Nouvelles

‘Caught between a rock and a hard place’: FDA considers over-the-counter birth control
France Dernières Nouvelles,France Actualités
  • 📰 politico
  • ⏱ Reading Time:
  • 90 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 59%

The agency is slated to make a decision on approval of the daily hormonal pill by this summer.

The Biden administration has long vowed to “follow the science” on drug approvals. But it has also pledged to aggressively defend reproductive rights.

The agency’s independent advisers met Tuesday and will meet Wednesday to review data from the pill’s maker to decide whether to recommend the FDA approve the drug, Opill, for over-the-counter sale. FDA approval would be a major step forward for the decadeslong campaign to have the U.S. join dozens of other countries where hormonal contraceptives are available without a prescription. A decision is expected sometime this summer.

But other experts say the Biden administration and the FDA face a difficult decision — and they’re likely to be excoriated and accused of political interference whether the pill is approved over the objections of FDA staff or rejected.The FDA and the White House did not respond to requests for comment.

Given Plan B’s approval history and the current political tug-of-war over reproductive rights access, lawsuits and citizen petitions are possible no matter what decision the FDA makes. | Justin Sullivan/Getty Images Advocates in favor of a non-prescription birth control pill held a demonstration outside the White House on Monday, featuring testimony from medical experts and teenagers who have encountered barriers to birth control access, as well as an obstacle course to symbolize what patients currently have to go through to get a prescription.

“When it comes to people being able to control their own reproductive destinies and desires, there always seems to be a lot more government involvement and control of what they can and cannot have easy access to,” said Sufrin. “There tends to be much easier access to less politically charged medications. Something as common as ibuprofen carries much higher risks of complications and high-risk events than the drug up for consideration for over-the-counter status.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

politico /  🏆 381. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

CAUGHT ON CAMERA: TSA handler caught yanking bomb-sniffing dogCAUGHT ON CAMERA: TSA handler caught yanking bomb-sniffing dogTSA says the dog was taken immediately to a veterinarian for a wellness exam and was found to be in good health.
Lire la suite »

Immuron stock rockets after FDA removes hold on IND of infectious diarrhea treatmentImmuron stock rockets after FDA removes hold on IND of infectious diarrhea treatmentThe U.S.-listed shares of Immuron Ltd. powered up 66.3% toward a one-year high in premarket trading Monday, after the Australia-based biopharmaceutical...
Lire la suite »

Samsung gets FDA clearance for irregular heart rhythm notificationsSamsung gets FDA clearance for irregular heart rhythm notificationsBut you’ll have to wait until One UI 5 Watch arrives later this year.
Lire la suite »

FDA raises concerns about over-the-counter birth control pillFDA raises concerns about over-the-counter birth control pillU.S. regulators will vote this week on whether the contraceptive Opill should be made widely available without a prescription.
Lire la suite »

FDA Recalls 500,000 COVID Test Kits Due to BacteriaFDA Recalls 500,000 COVID Test Kits Due to Bacteria🚨RECALL ALERT🚨: As many as half a million at-home COVID tests are being recalled due to potential bacterial contamination.
Lire la suite »



Render Time: 2025-03-09 05:22:18